Heart Failure Reviews

, Volume 16, Issue 3, pp 205–214 | Cite as

Past, present, and future of CRT



Cardiac resynchronization therapy is a key non-pharmacological treatment strategy for drug-refractory moderate-to-severe symptomatic heart failure in the presence of compromised left ventricular function and ventricular conduction delay. Because not all patients with conventional criteria benefit from CRT, continuous efforts have been directed toward improving patient selection; in particular, emerging echocardiographic criteria such as regional and global myocardial strains are being investigated to better predict CRT response. In the meantime, growing evidence from large randomized controlled trials (RCTs, REVERSE, and MADIT-CRT) has demonstrated that even mildly symptomatic patients may benefit from CRT. The role of CRT in heart failure patients with narrow QRS, however, remains to be defined in the scheme of larger RCTs (such as EchoCRT) as the ones carried out thus far (RethinQ and ESTEEM-CRT). Important experimental data derived from animal heart failure models are gradually elucidating the complex pathophysiological basis of cardiac dyssynchrony, which involves diffuse alterations from genome to structure. At the same time, technological breakthroughs, such as wireless endocardial cardiac pacing, will render the prospect of delivering CRT more precisely and more effectively, a reality in the near future.


Cardiac resynchronization therapy Ventricular dyssynchrony Cardiac pacing Heart failure 


  1. 1.
    Wiggers CJ (1925) The muscular reactions of mammalian ventricles to artificial surface stimuli. Am J Physiol 73:346–378Google Scholar
  2. 2.
    Thomas AC, Mower MM (1995) Multiple chambered pacing for treatment of congestive heart failure. Pacing Clin Electrophysiol 18(4 Pt 1):749–750 (No abstract available)PubMedCrossRefGoogle Scholar
  3. 3.
    Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M, Bailleul C, Daubert JC (2001) Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344:873–880PubMedCrossRefGoogle Scholar
  4. 4.
    Leclercq C, Walker S, Linde C, Clementy J, Marshall AJ, Ritter P, Djiane P, Mabo P, Levy T, Gadler F, Bailleul C, Daubert JC (2002) Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 23:1780–1787PubMedCrossRefGoogle Scholar
  5. 5.
    Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, Huth C, Schondube F, Wolfhard U, Bocker D, Krahnefeld O, Kirkels H (2002) Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 39:2026–2033PubMedCrossRefGoogle Scholar
  6. 6.
    Linde C, Leclercq C, Rex S, Garrigue S, Lavergne T, Cazeau S, McKenna W, Fitzgerald M, Deharo JC, Alonso C, Walker S, Braunschweig F, Bailleul C, Daubert JC (2002) Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 40:111–118PubMedCrossRefGoogle Scholar
  7. 7.
    Abraham WT, Fisher WG, Smith AL et al (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845–1853PubMedCrossRefGoogle Scholar
  8. 8.
    St John Sutton MG, Plappert T, Abraham WT et al (2003) Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107:1985–1990PubMedCrossRefGoogle Scholar
  9. 9.
    Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, Demets D, White BG, DeVries DW, Feldman AM, for the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. New Engl J Med 350:2140–2150PubMedCrossRefGoogle Scholar
  10. 10.
    Cleland JGF, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539–1549PubMedCrossRefGoogle Scholar
  11. 11.
    Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, on behalf of The CARE-HF Study Investigators (2006) Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the Cardiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J 27:1928–1932PubMedCrossRefGoogle Scholar
  12. 12.
    Rivero-Ayerza M, Theuns DA, Garcia-Garcia HM, Boersma E, Simoons M, Jordaens LJ (2006) Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. Eur Heart J 27:2682–2688PubMedCrossRefGoogle Scholar
  13. 13.
    Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, Yu CM, Gorcsan J III, St John Sutton M, De Sutter J, Murillo J (2008) Results of the predictors of response to CRT (PROSPECT) trial. Circulation 117:2608–2616PubMedCrossRefGoogle Scholar
  14. 14.
    Tanaka H, Nesser HJ, Buck T, Oyenuga O, Jánosi RA, Winter S, Saba S, Gorcsan J III (2010) Dyssynchrony by speckle-tracking echocardiography and response to cardiac resynchronization therapy: results of the Speckle Tracking and Resynchronization (STAR) study. Eur Heart J 31:1690–1700PubMedCrossRefGoogle Scholar
  15. 15.
    Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, van der Wall EE, Schalij MJ (2004) Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 44(9):1834–1840PubMedCrossRefGoogle Scholar
  16. 16.
    De Boeck BW, Teske AJ, Meine M, Leenders GE, Cramer MJ, Prinzen FW, Doevendans PA (2009) Septal rebound stretch reflects the functional substrate to cardiac resynchronization therapy and predicts volumetric and neurohormonal response. Eur J Heart Fail 11:863–871PubMedCrossRefGoogle Scholar
  17. 17.
    Helm RH, Leclercq C, Faris OP, Ozturk C, McVeigh E, Lardo AC, Kass DA (2005) Cardiac dyssynchrony analysis using circumferential versus longitudinal strain: implications for assessing cardiac resynchronization. Circulation 111:2760–2767PubMedCrossRefGoogle Scholar
  18. 18.
    Kirn B, Jansen A, Bracke F, van Gelder B, Arts T, Prinzen FW (2008) Mechanical discoordination rather than dyssynchrony predicts reverse remodeling upon cardiac resynchronization. Am J Physiol Heart Circ Physiol 295(2):H640–H646PubMedCrossRefGoogle Scholar
  19. 19.
    Bilchick KC, Dimaano V, Wu KC, Helm RH, Weiss RG, Lima JA, Berger RD, Tomaselli GF, Bluemke DA, Halperin HR, Abraham T, Kass DA, Lardo AC (2008) Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy. JACC Img 1:561–568CrossRefGoogle Scholar
  20. 20.
    van Bommel RJ, Bax JJ, Abraham WT, Chung ES, Pires LA, Tavazzi L, Zimetbaum PJ, Gerritse B, Kristiansen N, Ghio S (2009) Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis. Eur Heart J 30(20):2470–2477PubMedCrossRefGoogle Scholar
  21. 21.
    Klimusina J, Faletra F, DeBoeck B, Averaimo M, Casotti E, Pedrazzini G, Penco M, Moccetti T, Prinzen, Auricchio A (2010) Redistribution of left ventricular strain by cardiac resynchronization therapy in heart failure patients. Eur J Heart Fail (in press)Google Scholar
  22. 22.
    Muto C, Gasparini M, Neja CP, Iacopino S, Davinelli M, Zanon F, Dicandia C, Distefano G, Donati R, Calvi V, Denaro A, Tuccillo B (2010) Presence of left ventricular contractile reserve predicts mid-term response to cardiac resynchronization therapy—results from the LODO-CRT trial. Heart Rhythm (in press)Google Scholar
  23. 23.
    Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C (2008) Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 52:1834–1843PubMedCrossRefGoogle Scholar
  24. 24.
    Moss AJ, Hall WJ, Cannom DS et al (2009) Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361:1329–1338PubMedCrossRefGoogle Scholar
  25. 25.
    Cleland JG, Freemantle N, Daubert JC, Toff WD, Leisch F, Tavazzi L (2008) Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: a report from the CARE-HF study. Heart 94:278–283PubMedCrossRefGoogle Scholar
  26. 26.
    Zareba W, Klein H, Cygankiewicz I, Hall J, Goldberger J, Daubert JP, Gold, Rashtian M, Viskin S, Kargul W, Pitschner H, McNitt S, Moss AJ (2010) CRT-D effectiveness by QRS duration and morphology in the MADIT-CRT patients. Abstract. Heart Rhythm 5(7):S24Google Scholar
  27. 27.
    Tang AS, Wells GA, Arnold M, Connolly S, Hohnloser S, Nichol G, Rouleau J, Sheldon R, Talajic M (2009) Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial design. Curr Opin Cardiol 24:1–8PubMedCrossRefGoogle Scholar
  28. 28.
    Dickstein K, Bogale N, Priori S, Auricchio A, Cleland JG, Gitt A, Limbourg T, Linde C, van Veldhuisen DJ, Brugada J, Scientific Committee; National Coordinators (2009) The European cardiac resynchronization therapy survey. Eur Heart J 30:2450–2460PubMedCrossRefGoogle Scholar
  29. 29.
    Achilli A, Sassara M, Ficili S, Pontillo D, Achilli P, Alessi C, De Spirito S, Guerra R, Patruno N, Serra F (2003) Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and “narrow” QRS. J Am Coll Cardiol 42(12):2117–2124PubMedCrossRefGoogle Scholar
  30. 30.
    Yu CM, Chan YS, Zhang Q, Yip GW, Chan CK, Kum LC, Wu L, Lee AP, Lam YY, Fung JW (2006) Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol 48:2251–2257PubMedCrossRefGoogle Scholar
  31. 31.
    Bleeker GB, Holman ER, Steendijk P, Boersma E, van der Wall EE, Schalij MJ, Bax JJ (2006) Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol 48:2243–2250PubMedCrossRefGoogle Scholar
  32. 32.
    Jeevanantham V, Zareba W, Navaneethan S, Fitzgerald D, Yu CM, Achilli A, Bax J, Daubert J (2008) Metaanalysis on effects of cardiac resynchronization therapy in heart failure patients with narrow QRS complex. Cardiol J 15:230–236PubMedGoogle Scholar
  33. 33.
    Gasparini M, Regoli F, Galimberti P, Ceriotti C, Bonadies M, Mangiavacchi M, Andreuzzi B, Bragato R, Pini D, Klersy C, Gronda E (2007) Three years of cardiac resynchronization therapy: could superior benefits be obtained in patients with heart failure and narrow QRS? Pacing Clin Electrophysiol 30(Suppl 1):S34–S39PubMedGoogle Scholar
  34. 34.
    Beshai JF, Grimm RA, Nagueh SF, Baker JH II, Beau SL, Greenberg SM, Pires LA, Tchou PJ, for the RethinQ Study Investigators (2007) Cardiac resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med 357:2461–2471PubMedCrossRefGoogle Scholar
  35. 35.
    Beshai JF, Khunnawat C, Lin AC (2008) Mechanical dyssynchrony from the perspective of a cardiac electrophysiologist. Curr Opin Cardiol 23(5):447–451PubMedCrossRefGoogle Scholar
  36. 36.
    Gardin JM, Leifer ES, Fleg JL, Whellan D, Kokkinos P, Leblanc MH, Wolfel E, Kitzman DW, HF-ACTION Investigators (2009) Relationship of Doppler-Echocardiographic left ventricular diastolic function to exercise performance in systolic heart failure: the HF-ACTION study. Am Heart J 158(4 Suppl):S45–S52PubMedCrossRefGoogle Scholar
  37. 37.
    Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT). http://clinicaltrials.gov/ct2/show/NCT00683696
  38. 38.
    Vernooy K, Cornelussen RN, Verbeek XA, Vanagt WY, van Hunnik A, Kuiper M, Arts T, Crijns HJ, Prinzen FW (2007) Cardiac resynchronization therapy cures dyssynchronopathy in canine left bundle-branch block hearts. Eur Heart J 28(17):2148–2155PubMedCrossRefGoogle Scholar
  39. 39.
    Spragg DD, Leclercq C, Loghmani M, Faris OP, Tunin RS, DiSilvestre D, McVeigh ER, Tomaselli GF, Kass DA (2003) Regional alterations in protein expression in the dyssynchronous failing heart. Circulation 108:929–932PubMedCrossRefGoogle Scholar
  40. 40.
    Bilchick KC, Saha SK, Mikolajczyk E, Cope L, Ferguson WJ, Yu W, Girouard S, Kass DA (2006) Differential regional gene expression from cardiac dyssynchrony induced by chronic right ventricular free wall pacing in the mouse. Physiol Genomics 26:109–115PubMedCrossRefGoogle Scholar
  41. 41.
    Chakir K, Daya SK, Tunin RS, Helm RH, Byrne MJ, Dimaano VL, Lardo AC, Abraham TP, Tomaselli GF, Kass DA (2008) Reversal of global apoptosis and regional stress kinase activation by cardiac resynchronization. Circulation 117:1369–1377PubMedCrossRefGoogle Scholar
  42. 42.
    Barth AS, Aiba T, Halperin V, DiSilvestre D, Chakir K, Colantuoni C, Tunin RS, Dimaano VL, Yu W, Abraham TP, Kass DA, Tomaselli GF (2009) Cardiac resynchronization therapy corrects dyssynchrony-induced regional gene expression changes on a genomic level. Circ Cardiovasc Genet 2(4):371–378 [Epub 2009 May 15]PubMedCrossRefGoogle Scholar
  43. 43.
    Agnetti G, Kaludercic N, Kane LA, Elliott ST, Guo Y, Chakir K, Samantapudi D, Paolocci N, Tomaselli GF, Kass DA, Van Eyk JE (2010) Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts. Circ Cardiovasc Genet 3:78–87PubMedCrossRefGoogle Scholar
  44. 44.
    Saxon LA, Boehmer JP, Neuman S, Mullin CM (2007) Remote active monitoring in patients with heart failure (RAPID-RF): design and rationale. J Card Fail 13:241–246PubMedCrossRefGoogle Scholar
  45. 45.
    Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, Lamas GA, MOde Selection Trial Investigators (2003) Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107:2932–2937PubMedCrossRefGoogle Scholar
  46. 46.
    Yu CM, Chan JY, Zhang Q, Omar R, Yip GW, Hussin A, Fang F, Lam KH, Chan HC, Fung JW (2009) Biventricular pacing in patients with bradycardia and normal ejection fraction. N Engl J Med 361:2123–2134PubMedCrossRefGoogle Scholar
  47. 47.
    Mills RW, Cornelussen RN, Mulligan LJ, Strik M, Rademakers LM, Skadsberg ND, van Hunnik A, Kuiper M, Lampert A, Delhaas T, Prinzen FW (2009) Left ventricular septal and left ventricular apical pacing chronically maintain cardiac contractile coordination, pump function and efficiency. Circ Arrhythm Electrophysiol 2(5):571–579PubMedCrossRefGoogle Scholar
  48. 48.
    Kindermann M, Hennen B, Jung J, Geisel J, Böhm M, Fröhlig G (2006) Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE). J Am Coll Cardiol 47:1927–1937PubMedCrossRefGoogle Scholar
  49. 49.
    Doshi RN, Daoud EG, Fellows C, Turk K, Duran A, Hamdan MH, Pires LA, PAVE Study Group (2005) Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol 16(11):1160–1165PubMedCrossRefGoogle Scholar
  50. 50.
    van Geldorp IE, Vernooy K, Delhaas T, Prins MH, Crijns HJ, Prinzen FW, Dijkman B (2010) Beneficial effects of biventricular pacing in chronically right ventricular paced patients with mild cardiomyopathy. Europace 12:223–229PubMedCrossRefGoogle Scholar
  51. 51.
    Derval N, Steendijk P, Gula LJ, Deplagne A, Laborderie J, Sacher F, Knecht S, Wright M, Nault I, Ploux S, Ritter P, Bordachar P, Lafitte S, Réant P, Klein GJ, Narayan SM, Garrigue S, Hocini M, Haissaguerre M, Clementy J, Jaïs P (2010) Optimizing hemodynamics in heart failure patients by systematic screening of left ventricular pacing sites: the lateral left ventricular wall and the coronary sinus are rarely the best sites. J Am Coll Cardiol 55:566–575PubMedCrossRefGoogle Scholar
  52. 52.
    van Deursen C, van Geldorp IE, Rademakers LM, van Hunnik A, Kuiper M, Klersy C, Auricchio A, Prinzen FW (2009) Left ventricular endocardial pacing improves resynchronization therapy in canine left bundle-branch hearts. Circ Arrhythm Electrophysiol 2:580–587PubMedCrossRefGoogle Scholar
  53. 53.
    Lee KL, Lau CP, Tse HF, Echt DS, Heaven D, Smith W, Hood M (2007) First Human Demonstration of Cardiac Stimulation With Transcutaneous Ultrasound Energy Delivery Implications for Wireless Pacing With Implantable Devices. J Am Coll Cardiol 50:877–883PubMedCrossRefGoogle Scholar
  54. 54.
    Klersy C, De Silvestri A, Gabutti G, Regoli F, Auricchio A (2009) A meta-analysis of remote monitoring of heart failure patients. J Am Coll Cardiol 54:1683–1694PubMedCrossRefGoogle Scholar
  55. 55.
    Adamson PB, Kleckner KJ, VanHout WL, Srinivasan S, Abraham WT (2003) Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure. Circulation 108:266–269PubMedCrossRefGoogle Scholar
  56. 56.
    Ypenburg C, Bax JJ, van der Wall EE, Schalij MJ, van Erven L (2007) Intrathoracic impedance monitoring to predict decompensated heart failure. Am J Cardiol 99:554–557PubMedCrossRefGoogle Scholar
  57. 57.
    Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM Jr, Magalski A, Zile MR, Smith AL, Smart FW, O’Shaughnessy MA, Jessup ML, Sparks B, Naftel DL, Stevenson LW, COMPASS-HF Study Group (2008) Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol 51:1073–1079PubMedCrossRefGoogle Scholar
  58. 58.
    Page E, Cazeau S, Ritter P, Galley D, Casset C (2007) Physiological approach to monitor patients in congestive heart failure: application of a new implantable device-based system to monitor daily life activity and ventilation. Europace 9:687–693PubMedCrossRefGoogle Scholar
  59. 59.
    Singh JP, Rosenthal LS, Hranitzky PM, Berg KC, Mullin CM, Thackeray L, Kaplan A (2009) Device diagnostics and long-term clinical outcome in patients receiving cardiac resynchronization therapy. Europace 11:1647–1653PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Division of CardiologyFondazione Cardiocentro TicinoLuganoSwitzerland

Personalised recommendations